Clinicopathologic risk factors like age, sex, obesity, family history and expert pathology have been shown to have limited ability to predict progression to esophageal cancer. TissueCypher outperforms these risk factors and provides physicians with an actionable risk score and the patient’s personalized 5-year risk of progression.

Have questions about integrating
TissueCypher® into your practice?

Contact us to discuss the science behind our technology
and how TissueCypher® can be integrated into your practice.

Contact Us